Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells

Studies have shown that tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis in cancer cells. However, breast cancer cells are generally resistant to TRAIL. In the present study, we explored the effect of bufalin on TRAIL-induced breast cancer cell apoptosis. The results showed that bufalin enhanced TRAIL-induced apoptosis in MCF-7 and MDA-MB-231 breast cancer cells by activating the extrinsic apoptotic pathway. Bufalin also promoted the clustering of death receptor 4 (DR4) and DR5 in aggregated lipid rafts. The cholesterol-sequestering agent methyl-&bgr;-cyclodextrin reversed the DR4 and DR5 clustering and reduced bufalin+TRAIL-induced apoptosis. Overall, these results indicate that bufalin enhanced TRAIL-induced apoptosis in breast cancer cells by the partial redistribution of DRs in lipid rafts.

[1]  Ling Xu,et al.  Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells , 2012, Journal of Cancer Research and Clinical Oncology.

[2]  Ye Zhang,et al.  Epirubicin enhances TRAIL-induced apoptosis in gastric cancer cells by promoting death receptor clustering in lipid rafts. , 2011, Molecular medicine reports.

[3]  S. Oh,et al.  Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells. , 2011, Carcinogenesis.

[4]  Wei Tang,et al.  Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor. , 2011, International immunopharmacology.

[5]  Cheng Jiang,et al.  Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3/Mcl-1 pathway , 2011, Apoptosis.

[6]  B. Aggarwal,et al.  Zerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: Evidence for an essential role of reactive oxygen species. , 2009, Cancer research.

[7]  Ye Zhang,et al.  Oxaliplatin enhances TRAIL‐induced apoptosis in gastric cancer cells by CBL‐regulated death receptor redistribution in lipid rafts , 2009, FEBS letters.

[8]  R. Plummer,et al.  Phase 1 and Pharmacokinetic Study of Lexatumumab in Patients with Advanced Cancers , 2007, Clinical Cancer Research.

[9]  E. Solary,et al.  TRAIL in cancer therapy: present and future challenges , 2007, Expert opinion on therapeutic targets.

[10]  L. Andĕra,et al.  Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts , 2007, Molecular Cancer Therapeutics.

[11]  R. Evans,et al.  Disruption of Lipid Rafts Inhibits P2X1 Receptor-mediated Currents and Arterial Vasoconstriction* , 2005, Journal of Biological Chemistry.

[12]  T. Griffith,et al.  Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  L. Rajendran,et al.  Lipid rafts and membrane dynamics , 2005, Journal of Cell Science.

[14]  B. Fang,et al.  Mechanisms of resistance to TRAIL-induced apoptosis in cancer , 2005, Cancer Gene Therapy.

[15]  S. Fulda,et al.  Resveratrol-mediated sensitisation to TRAIL-induced apoptosis depends on death receptor and mitochondrial signalling. , 2005, European journal of cancer.

[16]  J. Lord,et al.  Clustering of death receptors in lipid rafts initiates neutrophil spontaneous apoptosis. , 2004, Biochemical Society transactions.

[17]  M. Piccart,et al.  Facts and controversies in systemic treatment of metastatic breast cancer. , 2004, The oncologist.

[18]  M. MacFarlane.  TRAIL-induced signalling and apoptosis. , 2003, Toxicology letters.

[19]  G. Rosen,et al.  Triptolide sensitizes lung cancer cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by inhibition of NF-κB activation , 2002, Experimental & Molecular Medicine.

[20]  J. Lord,et al.  The death-inducing signalling complex is recruited to lipid rafts in Fas-induced apoptosis. , 2002, Biochemical and biophysical research communications.

[21]  A. Ashkenazi,et al.  Targeting death and decoy receptors of the tumour-necrosis factor superfamily , 2002, Nature Reviews Cancer.

[22]  J. Dichgans,et al.  Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. , 1999, Biochemical and biophysical research communications.

[23]  M. Nau,et al.  Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. , 1999, Cancer research.

[24]  C. Rauch,et al.  Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo , 1999, Nature Medicine.

[25]  L. Krenn,et al.  Bufadienolides from animal and plant sources. , 1998, Phytochemistry.

[26]  M. Piccart,et al.  Monoclonal Antibody-Based Targeted Therapy in Breast Cancer , 2012, Drugs.